Peptide half-life, the property that shapes dosing intervals

What readers ask us next.

What does peptide half-life mean?

It is the time for the peptide's blood concentration to fall by half. Half-life largely determines how often a compound must be administered to maintain a level, so it shapes dosing intervals in the studies that used it. It is a pharmacokinetic property, independent of whether the peptide is effective or approved.

Why do natural peptides have such short half-lives?

The body breaks small signaling peptides down quickly using peptidases in blood and tissue and rapid kidney filtration, because natural hormones are meant to act briefly and then clear. This fast turnover is why unmodified peptides are often impractical as drugs without engineering to slow their clearance.

How is a peptide's half-life extended?

Developers use modifications such as albumin binding, as in the GHRH analog CJC-1295, amino acid substitutions that resist peptidase breakdown, and attachment of larger groups that slow kidney clearance. These changes can turn a signal lasting minutes into one lasting hours or days.

Does a longer half-life make a peptide better?

Not inherently. A longer half-life means less frequent administration and a steadier level, but it also means the compound and any side effects persist longer. Longer-lasting is a different pharmacokinetic profile, not automatically a safer or more effective one.

Adjacent in the literature.